LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Kong, Pingping"
  2. AU="Kakiuchi, Nobuyuki"
  3. AU=Ojelade Moriam
  4. AU="Gibson, D"
  5. AU="Hsu, Yi-Fan"
  6. AU="Tamoni, Alessandro"
  7. AU=Alexander Michael J
  8. AU="Mosazghi, Asmerom"

Suchergebnis

Treffer 1 - 5 von insgesamt 5

Suchoptionen

  1. Artikel: Analysis of the uterine artery pulsatility index on the day of endometrial transformation and pregnancy outcomes of patients undergoing frozen-thawed embryo transfer.

    Li, Li / Du, Mingze / Wu, Sheling / Wen, Caiyuzhu / Kong, Pingping / Zhang, Junwei / Guan, Yichun

    Frontiers in endocrinology

    2024  Band 15, Seite(n) 1278504

    Abstract: Objective: The objective was to analyze the impact of the uterine artery pulsatility index (PI) on pregnancy outcomes by measuring uterine artery blood flow on the day of endometrial transformation in patients undergoing frozen-thawed embryo transfer ( ... ...

    Abstract Objective: The objective was to analyze the impact of the uterine artery pulsatility index (PI) on pregnancy outcomes by measuring uterine artery blood flow on the day of endometrial transformation in patients undergoing frozen-thawed embryo transfer (FET).
    Methods: This was a case-control study. In total, 2,036 patients who underwent FET at the Third Affiliated Hospital of Zhengzhou University from October 2019 to September 2020 were included. The patients were divided into a clinical pregnancy group and a nonclinical pregnancy group according to pregnancy outcome. A multivariate logistic regression model was used to analyze the factors affecting the clinical pregnancy rate. The receiver operating characteristic (ROC) curve was used to determine the optimal mean PI cutoff value of 1.75. After 1:1 propensity score matching (PSM), 562 patients were included. For statistical description and analysis, the patients were divided into two groups: a group with a mean PI > 1.75 and a group with a mean PI ≤ 1.75.
    Results: The clinical pregnancy group included 1,218 cycles, and the nonclinical pregnancy group included 818 cycles. There were significant differences in female age (P<0.01), infertility type (P=0.04), baseline follicle-stimulating hormone level (P=0.04), anti-Müllerian hormone (AMH) level (P<0.01), antral follicle count (P<0.01), number of transferred embryos (P=0.045) and type of transferred embryo (P<0.01). There was no significant difference in the mean bilateral PI (1.98 ± 0.34 vs. 1.95 ± 0.35, P=0.10). The multivariate analysis results showed that maternal age (AOR=0.95, 95% CI=0.93-0.98, P<0.01), AMH level (AOR=1.00, 95% CI=1.00-1.01, P=0.045), number of transferred embryos (AOR=1.98, 95% CI=1.47-2.70, P<0.01), and type of transferred embryo (AOR=3.10, 95% CI=2.27-4.23, P<0.01) were independent factors influencing the clinical pregnancy rate. The mean PI (AOR=0.85, 95% CI=0.70-1.05; P=0.13) was not an independent factor influencing the clinical pregnancy rate. Participants were divided into two groups according to the mean PI cutoff value of 1.75, and there was no significant difference between the two groups (P > 0.05).
    Conclusion: In this study, we found that the uterine artery PI on the day of endometrial transformation in patients undergoing FET is not a good predictor of pregnancy outcomes.
    Mesh-Begriff(e) Humans ; Female ; Pregnancy ; Embryo Transfer/methods ; Adult ; Uterine Artery/diagnostic imaging ; Uterine Artery/physiology ; Pregnancy Outcome ; Case-Control Studies ; Pulsatile Flow/physiology ; Endometrium/blood supply ; Endometrium/diagnostic imaging ; Cryopreservation ; Pregnancy Rate ; Fertilization in Vitro/methods ; Retrospective Studies
    Sprache Englisch
    Erscheinungsdatum 2024-04-15
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2024.1278504
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: The relationships among gut microbiota, hypoxia-inducible factor and anaemia with chronic kidney disease.

    Liu, Lifen / Xu, Wenwen / Kong, Pingping / Dou, Yanna

    Nephrology (Carlton, Vic.)

    2022  Band 27, Heft 11, Seite(n) 851–858

    Abstract: Gut microbiota plays a vital role in human intestinal homeostasis, correlating strongly with the progression of numerous diseases. Recent researches provide powerful evidence that the connections exist between gut microbiota and renal anaemia. Gut ... ...

    Abstract Gut microbiota plays a vital role in human intestinal homeostasis, correlating strongly with the progression of numerous diseases. Recent researches provide powerful evidence that the connections exist between gut microbiota and renal anaemia. Gut microbiota may have an impact on renal anaemia by regulating the hypoxia-inducible factor (HIF) signalling, iron metabolism and inflammatory state. Because of this relationship, there may be potential treatments for renal anaemia. In this review, we will first provide an overview of current research progression on anaemia in chronic kidney disease and then introduce the relations among gut microbiota, HIF, and renal anaemia to explore the possible treatment options.
    Mesh-Begriff(e) Anemia/etiology ; Gastrointestinal Microbiome ; Humans ; Hypoxia/complications ; Iron ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/metabolism ; Renal Insufficiency, Chronic/therapy
    Chemische Substanzen Iron (E1UOL152H7)
    Sprache Englisch
    Erscheinungsdatum 2022-06-05
    Erscheinungsland Australia
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1303661-0
    ISSN 1440-1797 ; 1320-5358
    ISSN (online) 1440-1797
    ISSN 1320-5358
    DOI 10.1111/nep.14064
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Optimal waiting period for frozen embryo transfer after hysteroscopic polypectomy: A propensity score matching analysis.

    Wang, Bijun / Meng, Nan / Zhang, Wenjuan / Kong, Pingping / Liu, Zhaozhao / Liu, Wenxia / Sun, Huaqing / Zhang, Wen / Ren, Chenchen / Guan, Yichun

    Frontiers in endocrinology

    2022  Band 13, Seite(n) 986809

    Abstract: Objective: To evaluate the optimal waiting period for frozen-thawed embryo transfer (FET) after hysteroscopic polypectomy (HSC-P).: Design: Retrospective cohort.: Setting: University-affiliated hospital.: Patients: All patients included in this ...

    Abstract Objective: To evaluate the optimal waiting period for frozen-thawed embryo transfer (FET) after hysteroscopic polypectomy (HSC-P).
    Design: Retrospective cohort.
    Setting: University-affiliated hospital.
    Patients: All patients included in this research underwent hysteroscopy before the first FET cycle after whole embryo freezing. A total of 206 patients had undergone HSC-P, and 3681 patients without endometrial polyps were defined as the controls.
    Interventions: HSC-P.
    Main outcome measures: The HSC-P group was divided into three subgroups based on the time interval between HSC-P and the start of an FET cycle. Subgroup 1 consisted of patients who underwent FET after their next menses, subgroup 2 after two menstrual cycles, and subgroup 3 after three or more menstrual cycles. Demographics, baseline
    Results: There were 137 patients in subgroup 1, 40 in subgroup 2, and 29 in subgroup 3. There were no differences in the baseline characteristics of the three groups. IVF-related data and FET-related data, such as endometrial thickness and ET no. Of embryoes, were similar among the three subgroups. The three subgroups showed no significant differences in implantation rate, biochemical pregnancy rate, abortion rate, clinical pregnancy rate or live birth rate. Besides, There was no significant difference in perinatal outcomes including very preterm delivery, preterm delivery, low birth weight, macrosomia, small for gestational age, large for gestational age, birth weight(g), birth-height(cm)and Apgar Scores.
    Conclusions: Compared with FET after their next menses, FET after two or more menstrual cycles after HSC-P does not necessarily produce superior outcomes.
    Mesh-Begriff(e) Embryo Transfer ; Female ; Humans ; Infant, Newborn ; Pregnancy ; Pregnancy Rate ; Premature Birth ; Propensity Score ; Retrospective Studies
    Sprache Englisch
    Erscheinungsdatum 2022-09-30
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2022.986809
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Clinical and genetic analysis of an isolated follicle-stimulating hormone deficiency female patient.

    Zhu, Lixia / Xiao, Nan / Zhang, Tao / Kong, Pingping / Xu, Bei / Fang, Zishui / Jin, Lei

    Journal of assisted reproduction and genetics

    2020  Band 37, Heft 6, Seite(n) 1441–1448

    Abstract: Objective: To characterize the clinical features of a female patient with isolated follicle-stimulating hormone (FSH) deficiency and to investigate the underlying mechanisms of FSH inactivation.: Methods: The proband was a 29-year-old woman with ... ...

    Abstract Objective: To characterize the clinical features of a female patient with isolated follicle-stimulating hormone (FSH) deficiency and to investigate the underlying mechanisms of FSH inactivation.
    Methods: The proband was a 29-year-old woman with primary amenorrhea, impaired pubertal development, and infertility. Subsequently, reproductive endocrine was screened. DNA sequencing was conducted for the identification of FSHβ mutation. RT-PCR, western blots, in vitro immunometric assay, and bioassay were performed to confirm the impact of the mutation on FSH expression and biological activity. Molecular model consisting of FSHα and mutant FSHβ subunit was built for the structural analysis of FSH protein.
    Results: The evaluation of reproductive endocrine revealed undetectable basal and GnRH-stimulated serum FSH. Sequencing of the FSHβ gene identified a homozygous nonsense mutation at codon 97 (Arg97X). RT-PCR and western blot analysis revealed the mutation Arg97X did not affect FSHβ mRNA and protein expression. But in vitro immunometric assay and bioassay demonstrated the production of normal bioactive FSH protein was disturbed by the mutation Arg97X. Structural analysis showed the surface structure of the resulting mutant FSH presented with lock-and-key, mosaic binding pattern, while the native structure was an encircling binding mode.
    Conclusion: The mutation Arg97X could disturb structural stability of the resulting FSH protein consisting of FSHα and mutant FSHβ subunit, which may lead to FSH deficiency.
    Mesh-Begriff(e) Adult ; Amenorrhea/genetics ; Amenorrhea/pathology ; Female ; Follicle Stimulating Hormone/deficiency ; Follicle Stimulating Hormone/genetics ; Follicle Stimulating Hormone, beta Subunit/deficiency ; Follicle Stimulating Hormone, beta Subunit/genetics ; Genetic Testing ; Homozygote ; Humans ; Mutation/genetics ; Oligospermia/diagnosis ; Oligospermia/genetics ; Oligospermia/pathology
    Chemische Substanzen Follicle Stimulating Hormone, beta Subunit ; Follicle Stimulating Hormone (9002-68-0)
    Sprache Englisch
    Erscheinungsdatum 2020-05-05
    Erscheinungsland Netherlands
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 1112577-9
    ISSN 1573-7330 ; 1058-0468
    ISSN (online) 1573-7330
    ISSN 1058-0468
    DOI 10.1007/s10815-020-01786-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.

    Guan, Yichun / Kong, Pingping / Xiao, Zhiying / Zhang, Junyan / He, Jingfang / Geng, Wenjun / Yan, Junfang / Sun, Simin / Mu, Mingkun / Du, Xiaofang / Wang, Xingling

    Frontiers in endocrinology

    2022  Band 12, Seite(n) 728051

    Abstract: Objective: To assess whether women of advanced age (≥35 years) with polycystic ovary syndrome (PCOS) have the same cumulative live birth rate (CLBR) as their age-matched controls with tubal factor infertility and to determine the influencing factors on ... ...

    Abstract Objective: To assess whether women of advanced age (≥35 years) with polycystic ovary syndrome (PCOS) have the same cumulative live birth rate (CLBR) as their age-matched controls with tubal factor infertility and to determine the influencing factors on the CLBRs of aged women.
    Design: A retrospective cohort study.
    Setting and population: A total of 160 women of advanced age (≥35 years) with PCOS and 1073 women with tubal factor infertility were included in our study. All patients underwent their first fresh cycles and subsequent frozen cycles within in one year in our centre from 2015 to 2020.
    Methods: To determine independent influencing factors on the CLBRs of these aged patients, a multivariable Cox regression model of CLBR according to the transfer cycle type was constructed.
    Result: The Cox regression model of the CLBRs indicated that there was no significant difference between the PCOS group and the tubal infertility group in terms of advanced age (HR, 0.95; 95% CI, 0.71-1.27,
    Conclusion: Despite the higher number of oocytes retrieved in PCOS patients, the reproductive window is not extended for PCOS patients compared with tubal factor infertility patients. Age, AMH and the number of oocytes retrieved play crucial roles in the CLBRs of patients of advanced age (≥35 years).
    Mesh-Begriff(e) Adult ; Anti-Mullerian Hormone/metabolism ; Case-Control Studies ; Cohort Studies ; Embryo Transfer ; Fallopian Tube Diseases/complications ; Female ; Fertilization in Vitro ; Humans ; Infertility, Female/etiology ; Infertility, Female/metabolism ; Infertility, Female/therapy ; Live Birth/epidemiology ; Polycystic Ovary Syndrome/complications ; Polycystic Ovary Syndrome/metabolism ; Polycystic Ovary Syndrome/therapy ; Pregnancy ; Pregnancy Rate ; Retrospective Studies ; Sperm Injections, Intracytoplasmic ; Treatment Outcome
    Chemische Substanzen Anti-Mullerian Hormone (80497-65-0)
    Sprache Englisch
    Erscheinungsdatum 2022-01-17
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2021.728051
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang